These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22926003)

  • 41. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
    Mohseni AH; Razavilar V; Keyvani H; Razavi MR; Khavari-Nejad RA
    J Med Virol; 2019 Feb; 91(2):296-307. PubMed ID: 30192395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients.
    Bolhassani A; Zahedifard F; Taslimi Y; Taghikhani M; Nahavandian B; Rafati S
    Indian J Med Res; 2009 Nov; 130(5):533-41. PubMed ID: 20090101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers.
    Radaelli A; De Giuli Morghen C; Zanotto C; Pacchioni S; Bissa M; Franconi R; Massa S; Paolini F; Muller A; Venuti A
    Virus Res; 2012 Dec; 170(1-2):44-52. PubMed ID: 22951311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fusion of a tumour-associated antigen to HIV-1 Tat improves protein-based immunotherapy of cancer.
    Giannouli C; Brulet JM; Gesché F; Rappaport J; Burny A; Leo O; Hallez S
    Anticancer Res; 2003; 23(4):3523-31. PubMed ID: 12926102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
    Diniz MO; Cariri FA; Aps LR; Ferreira LC
    Hum Gene Ther; 2013 Oct; 24(10):861-70. PubMed ID: 24007495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
    Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC
    Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies.
    Peng S; Trimble C; Ji H; He L; Tsai YC; Macaes B; Hung CF; Wu TC
    J Biomed Sci; 2005 Oct; 12(5):689-700. PubMed ID: 16200349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An E7-based therapeutic vaccine protects mice against HPV16 associated cancer.
    Venuti A; Massa S; Mett V; Vedova LD; Paolini F; Franconi R; Yusibov V
    Vaccine; 2009 May; 27(25-26):3395-7. PubMed ID: 19200826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
    Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
    Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
    Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
    Hsu KF; Hung CF; Cheng WF; He L; Slater LA; Ling M; Wu TC
    Gene Ther; 2001 Mar; 8(5):376-83. PubMed ID: 11313814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.
    Haigh O; Kattenbelt J; Cochrane M; Thomson S; Gould A; Tindle R
    Cancer Gene Ther; 2010 Oct; 17(10):708-20. PubMed ID: 20539319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines.
    Talebi S; Bolhassani A; Sadat SM; Vahabpour R; Agi E; Shahbazi S
    Biomed Pharmacother; 2017 Jan; 85():148-154. PubMed ID: 27930979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.
    Smahel M; Poláková I; Pokorná D; Ludvíková V; Dusková M; Vlasák J
    Int J Oncol; 2008 Jul; 33(1):93-101. PubMed ID: 18575754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines.
    Shahbazi S; Bolhassani A
    Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
    Best SR; Peng S; Juang CM; Hung CF; Hannaman D; Saunders JR; Wu TC; Pai SI
    Vaccine; 2009 Sep; 27(40):5450-9. PubMed ID: 19622402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.